Literature DB >> 19683364

[Factors related to non-prescription of tuberculin skin testing in a cohort of HIV-infected people].

Asunción Díaz1, Mercedes Diez, María José Bleda, Mikel Aldamiz, Mikel Camafort, Xavier Camino, Concepción Cepeda, Asunción Costa, Oscar Ferrero, Paloma Geijo, José Antonio Iribarren, Santiago Moreno, María Elena Moreno, Pablo Labarga, Javier Pinilla, Joseba Portu, Federico Pulido, Carmen Rosa, Juan Miguel Santamaría, Mauricio Telenti, Luis Trapiella, Mónica Trastoy, Pompeyo Viciana.   

Abstract

INTRODUCTION: Tuberculin skin testing (TST) for tuberculosis (TB) is recommended for all patients with HIV infection because of the known relationship between these two conditions. In this report we analyze the incidence and variables associated with non-prescription of TST in a cohort of HIV-infected people. PATIENTS AND METHODS: Longitudinal study conducted between 2000 and 2002 at 10 HIV hospital-based clinics. All HIV-infected patients who had not been regularly followed-up previously in dedicated clinics were identified. Data about TST and other variables related to TB were obtained from the clinical records. We calculated the percentage of patients who did not undergo TST and the associated factors, using odds ratios (ORs) and the 95% CI to investigate associations. A multivariate logistic regression analysis was performed.
RESULTS: A total of 1242 patients met the inclusion criteria. TST was not performed in 185 patients (17.6% of those eligible). The fact of being an intravenous drug abuser was associated with a higher probability of TST non-prescription (OR: 2.6, 95% CI 1.1-6.5), whereas being unemployed (OR: 0.6, 95% CI 0.3-1.0), having a CD4 cell count >200 (CD4 200-499: OR 0.5, 95% CI 0.3-0.9. CD4> or =500: OR 0.3, 95% CI 0.2-0.6), and contact with persons with TB (OR 0.2, 95% CI 0.1-0.5) were associated with a lower probability.
CONCLUSIONS: In this study, the percentage of TST non-prescription was quite high. The results suggest that TST non-prescription in this population is related to the clinicians' expectations regarding the results of the test and the patients' adherence to treatment for latent TB infection. Copyright 2008 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19683364     DOI: 10.1016/j.eimc.2009.06.008

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  1 in total

1.  Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain.

Authors:  Asuncion Diaz; Mercedes Diez; Maria Jose Bleda; Mikel Aldamiz; Miguel Camafort; Xabier Camino; Concepcion Cepeda; Asuncion Costa; Oscar Ferrero; Paloma Geijo; Jose Antonio Iribarren; Santiago Moreno; Maria Elena Moreno; Pablo Labarga; Javier Pinilla; Joseba Portu; Federico Pulido; Carmen Rosa; Juan Miguel Santamaría; Mauricio Telenti; Luis Trapiella; Monica Trastoy; Pompeyo Viciana
Journal:  BMC Infect Dis       Date:  2010-09-14       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.